Christi Shaw, inspired by her sister’s cancer, named CEO of Kite Pharma, Gilead’s anti-cancer unit
KITE PHARMA
Kite Pharma, a unit of biotechnology giant Gilead, is focused on treatments that genetically engineer patients’ white blood cells to attack cancer.
No hay comentarios:
Publicar un comentario